Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
MOUNIER-JACK, S; RUDGE, JW; Phetsouvanh, R; Chanthapadith, C; COKER, R;
2010
Health policy and planning, (2010).25 Sup Suppl. 10.1093/heapol/czq056.
Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months.
Noor, RA; Thiesen, M; Mordmuller, B; MILLIGAN, P; Atuguba, F; Sirima, S; Issifou, S; BOJANG, K; Kironde, F; Tiono, A; Okech, B; Chilengi, R; Ngoa, A; Mukasa, K; Jepsen, S;
2010
Malaria journal, (2010).9 Suppl 2 10.1186/1475-2875-9-s2-p26.
Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.
White, MT; Griffin, JT; RILEY, EM; DRAKELEY, CJ; Moorman, AM; Sumba, PO; Kazura, JW; Ghani, AC; John, CC;
2010
Proceedings Biological sciences / The Royal Society, (2010).278 1710 10.1098/rspb.2010.1697.
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.
Russell, FM; Carapetis, JR; Satzke, C; Tikoduadua, L; Waqatakirewa, L; Chandra, R; Seduadua, A; Oftadeh, S; Cheung, YB; Gilbert, GL; MULHOLLAND, EK;
2010
Clinical and vaccine immunology, (2010).17 12 10.1128/CVI.00117-10.
Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
Hajjeh, RA; Privor-Dumm, L; EDMOND, K; O'Loughlin, R; Shetty, S; GRIFFITHS, UK; Bear, AP; COHEN, AL; Chandran, A; Schuchat, A; MULHOLLAND, EK; Santosham, M;
2010
Vaccine, (2010).28 43 10.1016/j.vaccine.2010.07.028.
Global use of Haemophilus influenzae type b conjugate vaccine.
Ojo, LR; O'Loughlin, RE; COHEN, AL; Loo, JD; EDMOND, KM; Shetty, SS; Bear, AP; Privor-Dumm, L; GRIFFITHS, UK; Hajjeh, R;
2010
Vaccine, (2010).28 43 10.1016/j.vaccine.2010.07.074.
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
Agnandji, ST; ASANTE, KP; Lyimo, J; Vekemans, J; Soulanoudjingar, SS; Owusu, R; Shomari, M; Leach, A; Fernandes, J; DOSOO, D; Chikawe, M; Issifou, S; Osei-Kwakye, K; Lievens, M; Paricek, M; Apanga, S; Mwangoka, G; Okissi, B; Kwara, E; Minja, R; Lange, J; Boahen, O; Kayan, K; Adjei, G; CHANDRAMOHAN, D; ... Abdulla, S.
2010
The Journal of infectious diseases, (2010).202 7 10.1086/656190.
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.
Weinberger, DM; Harboe, ZB; Sanders, EA M; Ndiritu, M; Klugman, KP; Rückinger, S; Dagan, R; Adegbola, R; Cutts, F; Johnson, HL; O'Brien, KL; SCOTT, JA; Lipsitch, M;
2010
Clinical infectious diseases, (2010).51 6 10.1086/655828.
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
JOBARTEH, M; Malfroy, M; Peterson, I; Jeng, A; Sarge-Njie, R; Alabi, A; Peterson, K; COTTEN, M; Hall, A; Rowland-Jones, S; Whittle, H; Tedder, R; Jaye, A; Mendy, M;
2010
Virology journal, (2010).7 1 10.1186/1743-422X-7-230.
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.
Mordmüller, B; Szywon, K; Greutelaers, B; Esen, M; Mewono, L; Treut, C; Mürbeth, RE; Chilengi, R; Noor, R; Kilama, WL; Imoukhuede, EB; Imbault, N; Leroy, O; Theisen, M; Jepsen, S; MILLIGAN, P; Fendel, R; Kremsner, PG; Issifou, S;
2010
Vaccine, (2010).28 41 10.1016/j.vaccine.2010.07.085.